Rheumatology

Women

Questions discussed in this category

Would you consider using transdermal estrogen in a patient with “high risk” APLS patient on warfarin?

Both VTE and arterial thrombosis (CVA) prior to starting warfarin. Lupus anticoagulant positive. Has severe post menopausal symptoms.

2 Answers available

What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?

1 Answer available

Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?

1 Answer available

Do you consider co-prescribing hormone therapy and anticoagulation in a patient with prior DVT and uncontrollable VSM uncontrolled by non-hormonal therapies?

4 Answers available

Papers discussed in this category

Blood, 2015 Dec 22

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

Menopause (New York, N.Y.), 2024 Feb 01

Does hormone therapy exacerbate other venous thromboembolism risk factors?

Research and practice in thrombosis and haemostasis, 2023 Apr 24

Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.

Arthritis Rheumatol, 2020 Apr

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

Menopause (New York, N.Y.), 2022 Jan 14

Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: a scoping review.

Related Topics in Rheumatology